Advertisement
Advertisement
U.S. markets open in 4 hours 10 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
188.77+7.81 (+4.32%)
At close: 04:00PM EDT
188.77 0.00 (0.00%)
After hours: 04:53PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • A
    Anthony
    Trading with an expert is the best strategy newbies and busy investors who have little or no time to monitor trade .. I will advise you to stop trading on your own it's very risky . Seek advice from a professional expert analyst who can monitor your trading well that why I will always introduce mr Michael Novogartz and expert analyst to any investor been investing with for years now highly recommended his contact via Tele➖gram
    https://t.me/Michael_Novogratz_1.
    Or Whatzpp +1 386 282 7817
  • L
    LEEHAN
    Wow! I just found a site that gives the top stocks to trade every single day for free! (http://traderspot.club)
  • J
    Jim
    This is getting old fast..
  • T
    Tom Johnson
    Why are we not a BUYOUT candidate? are we open to that discussion for a 20-40% premium of course.....
  • M
    MICHAEL
    PHDGAFFMAN

    I have been reading posts by a select few for over a decade and half when RGEN
    was still making drugs. I, like a couple of you, have been holding on for years. I was the proud owner of
    2000 shares purchased close to $4.00 and only when it hit $190.00 did I sell 600 shares. I , once again,
    like a couple of you, have sat thru some antagonizing drops in share price , enough for me personally to
    question my own sanity. After all these years of reading posts, I am finally letting you guys know, I've been
    their all the way.
    Bullish
  • J
    Jim
    Anyone make sense of this?

    Statement of Ownership (sc 13g)
    September 08 2022 - 01:44PM
    Edgar (US Regulatory)
    Alert
    Print
    Share On Facebook

    us7599161095_090722.txt

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No: )
    REPLIGEN CORPORATION
    (Name of Issuer)

    Common Stock
    (Title of Class of Securities)

    759916109
    (CUSIP Number)

    August 31, 2022
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to
    which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No. 759916109

    (1)Names of reporting persons. BlackRock, Inc.

    (2) Check the appropriate box if a member of a group
    (a) [ ]
    (b) [X]

    (3) SEC use only

    (4) Citizenship or place of organization

    Delaware

    Number of shares beneficially owned by each reporting person with:

    (5) Sole voting power

    5524374

    (6) Shared voting power

    0

    (7) Sole dispositive power

    5686997

    (8) Shared dispositive power

    0

    (9) Aggregate amount beneficially owned by each reporting person

    5686997

    (10) Check if the aggregate amount in Row (9) excludes certain shares

    (11) Percent of class represented by amount in Row 9

    10.2%

    (12) Type of reporting person

    HC

    Item 1.

    Item 1(a) Name of issuer:
    -----------------------------------------------------------------------

    REPLIGEN CORPORATION

    Item 1(b) Address of issuer's principal executive offices:
    -----------------------------------------------------------------------

    41 SEYON STREET BUILDING 1, SUITE 100
    WALTHAM MA 02453

    Item 2.

    2(a) Name of person filing:
    ----------------------------------------------------------------------
    BlackRock, Inc.

    2(b) Address or principal business office or, if none, residence:
    -----------------------------------------------------------------------
    BlackRock, Inc.
    55 East 52nd Street
    New York, NY 10055

    2(c) Citizenship:
    --------------------------------------------------------------------
    See Item 4 of Cover Page

    2(d) Title of class of securities:
    -------------------------------------------------------------------

    Common Stock

    2(e) CUSIP No.:
    See Cover Page

    Item 3.

    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c),
    check whether the person filing is a:
    [ ] Broker or dealer registered under Section 15 of the Act;
    [ ] Bank as defined in Section 3(a)(6) of the Act;
    [ ] Insurance company as defined in Section 3(a)(19) of the Act;
    [ ] Investment company registered under Section 8 of the
    Investment Company Act of 1940;
    [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
    [ ] An employee benefit plan or endowment fund in accordance with
    Rule 13d-1(b)(1)(ii)(F);
    [X] A parent holding company or control person in accordance with
    Rule 13d-1(b)(1)(ii)(G);
    [ ] A savings associations as defined in Section 3(b) of the Federal
    Deposit Insurance Act (12 U.S.C. 1813);
    [ ] A church plan that is excluded from the definition of an
    investment company under section 3(c)(14) of the Investment Company
    Act of 1940;
    [ ] A non-U.S. institution in accordance with
    Rule 240.13d-1(b)(1)(ii)(J);
    [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing
    as a non-U.S. institution in accordance with
    Rule 240.13d-1(b)(1)(ii)(J), please specify the type of
    institution:

    Item 4. Ownership

    Provide the following information regarding the aggregate number
    and percentage of the class of securities of the issuer identified in Item 1.

    Amount beneficially owned:

    5686997

    Percent of class

    10.2%

    Number of shares as to which such person has:

    Sole power to vote or to direct the vote

    5524374

    Shared power to vote or to direct the vote

    0

    Sole power to dispose or to direct the disposition of

    5686997

    Shared power to dispose or to direct the disposition of

    0

    Item 5.

    Ownership of 5 Percent or Less of a Class. If this statement is being
    filed to report the fact that as of the date hereof the reporting person
    has ceased to be the beneficial owner of more than 5 percent of the
    class of securities, check the following [ ].

    Item 6. Ownership of More than 5 Percent on Behalf of Another Person

    If any other person is known to have the right to receive or the power
    to dire
  • J
    Jim
    What woke up the sleeping giant today? Up 5%.
  • T
    Tom Johnson
    As you always thrilled with performance and guidance. Big thank you to tony hunt and staff as well as walt herlihy.... GRATEFUL for your business acumen and hard work.
  • J
    Jim
    RGEN within $2 of a 52 week high!
  • U
    Updated
    Yet another beat and raise.
    This company continues to expand, its a "arms dealer" to the biotech industry.....with the products that continue to exceed their customers expectations. Excellence!!
  • B
    BROBERG
    Do you guys follow (http://Themaxgains.tech)? It seems way better than all the spam on the RGEN board - The alerts have been great!
Advertisement
Advertisement